The aim was to determine diagnostic value of serum prolactin levels in the diff
INTRODUCTION
Epileptic seizure (ES) is a clinical condition made up of temporary symptoms and/or fi ndings due to abnormally excessive and synchronized neuronal discharges in the brain (1) . Epilepsy is a tendency of the brain to form epileptic seizures plus at least one epileptic seizure (2) . Clinical and electrographic classifi cations of epileptic seizures were issued by the International League against Epilepsy (ILAE) in 1981 and are still widely accepted throughout the world (3) . We may encounter epilepsy in many clinical forms. The clinical properties, etiology, severity and prognosis of epilepsy with concomitant neurological fi ndings are highly variable. For this reason, the diff erential diagnosis of epilepsy and nonepileptic seizures (NES) may be diffi cult (4) . The authors report that 20%-25% of patients who are referred to epilepsy clinic do not really have epilepsy (5) . Similarly, 10%-15% of children diagnosed with treatment-resistant epilepsy actually have nonepileptic attacks (6) . The most common misdiagnoses include syncope (44%), psychiatric disorders (20%), breath holding spells (11%), migraine and night terror (12%), and other rare reasons (11%) (5).
Prolactin (PRL) is a polypeptide hormone secreted from the lactotrope cells of the anterior hypophysis and its secretion aff ects sleep, stress, surgical interventions and antiepileptic medication (7, 8) . The increase in PRL levels following an ES has been known for approximately 40 years (9) . It has also been proven that the type, localization and duration of the seizure aff ect PRL secretion (10) . Video-electroencephalography (video-EEG) is defi nitely the gold standard in the differential diagnosis of ES and NES. However, it is not applicable in emergency services. Although there are many studies evaluating PRL levels in the postictal period for the diff erential diagnosis of ES and NES, the studies done on children are limited.
In our study, it was aimed to measure serum PRL levels at 10 and 60 min for the diff erential diagnosis of ES and NES in children aged one month to 18 years.
PATIENTS AND METHODS
The study was carried out at the Adana Numune Education and Research Hospital, Adana, Turkey (ethical approval no. 31032010/17). The study included 131 children aged one month to 18 years, referred to our Pediatrics and Emergency Policlinics, Adana Numune Research and Training Hospital, for seizure complaints. An informed consent was obtained from parents/guardians of all study participants. As the study was planned as a prospective one, 31 cases with liver and/or kidney dysfunction, electrolyte imbalance, fi ndings of intracranial infection, or a history of medication use other than antiepileptic medications were excluded.
The cases were divided into patient and control groups. Patient group included 50 patients (32 female and 18 male) admitted to our pediatrics and/or emergency units within 10 minutes of seizure complaint and thought to have sustained ES after detailed history and physical examination (group 1). Another 50 patients (29 female and 21 male) admitted to our pediatrics and/or emergency units within 10 minutes of seizure complaint and thought to have had NES after detailed history and physical examination were included in control group (group 2). Sleep EEG was performed in patients of both groups only once in the postictal period, approximately ten days after admission to the hospital.
Venous blood was drawn in all patients at postictal 10 min and 60 min using 5-mL vacuumed tubes without anticoagulants. The samples were kept at room temperature for coagulation and centrifuged for 10 min at 3000 G. Sample PRL levels were measured on an ADVIA Centaur XP (Siemens Healthcare Diagnostics Inc., Tarrytown, USA), a fully automated immunoautoanalyzer with original Siemens kits using the chemiluminometric method. The reference range of serum PRL was 2.1-17.7 ng/mL (11) .
Statistical analysis
Statistical data analysis was done by use of the SPSS 15.00 package program. Mann Whitney U test, used on comparison of two groups that did not show normal distribution, and Kruskal Wallis test was used on general comparison among more than two groups. Dual Mann Whitney U test was used for signifi cant fi ndings obtained on comparison of more than two groups, while Bonferroni-adjusted Mann Whitney U test was used on comparison of subgroups. Spearman rank correlation analysis was used to analyze correlation between quantitative measurements. The level of signifi cance was set at p=0.05 in all tests.
RESULTS
The mean age of 50 patients in group 1 (epileptic seizure group, patient group) was 5.8±5.3 years; there were 32 (64%) female and 18 (36%) male patients. The mean age of 50 patients in group 2 (nonepileptic seizure group, control group) was 11±5.8 years; there were 29 (58%) female and 21 (42%) male patients. The mean age was signifi cantly lower in the epileptic seizure group (p<0.001). There was no statistically signifi cant between-group diff erence according to gender (p>0.05).
Twenty-three group 1 patients had been previously diagnosed with epilepsy and 21 of them had been using antiepileptic medications. The remaining 27 patients were newly diagnosed. When the groups were compared according to the duration of seizures, no signifi cant diff erence was found between the groups (p>0.05). The interictal EEGs of 38 patients were interpreted as pathological. EEGs were normal in all group 2 patients. In group 2, 15 (30%) patients were diagnosed with syncope, 20 (40%) with conversion, ten (20%) with breath holding spells, and fi ve (10%) with night terrors. Demographic and clinical characteristics of study patients are shown in Table 1 .
When serum PRL levels were evaluated according to the postictal drawing time, the 10-min serum PRL levels were found to be statistically signifi cantly higher in group 1 as compared with group 2 (p<0.001), but there was no statistically signifi cant between-group diff erence in serum PRL levels at 60 min (p>0.05). The 10-min and 60-min serum PRL levels are shown in Table 2 .
DISCUSSION
Convulsions account for 1%-2% of admissions to emergency department (12) . Video-EEG is the gold standard for diff erential diagnosis of epilepsy in clinical setting; however, it is expensive and usually not available (13) . There is a known need of a parameter that can be used routinely to diff erentiate ES and NES. It has been reported that serum PRL levels, significantly increasing after ES and not signifi cantly changing after NES except for syncope, could be used as an important marker on diff erential diagnosis (13) . The hypothesis of increased PRL secretion during the ictal period is being defended. In 1978, Trimble et al. were the fi rst to report in the literature that PRL levels were signifi cantly higher in patients with ES as compared with patients that had NES (9).
The studies of ES and NES in children and adolescents are highly limited. In our study, we found a statistically significant age diff erence between the ES and NES groups. We believe that the age increase in the NES group may be due to conversions. The American Academy of Neurology suggests evaluation of PRL levels in adults and older children to diff erentiate generalized tonic-clonic seizures or complex partial seizures from psychogenic NES at 10-20 min following the attack and interpreting the results in favor of generalized tonic-clonic or partial seizures in case of increased results (14) . Yerby et al. (13) report that the postictal serum PRL levels used for diff erential diagnosis of ES and NES are not increased in nonepileptic cases in contrast to epileptic cases, and Luef (15) reports that the 15-20 min serum PRL increase may be helpful in diff erentiating between psychogenic and complex partial and generalized tonic-clonic seizures but may not be of help in diff erentiating between epileptic seizure and syncope.
The results obtained in our study showed that serum PRL levels increased signifi cantly in epilepsies. Considering the diff erence and time diff erence between the groups, it was found that the 10-min serum PRL levels were higher in the epileptic group as compared with the nonepileptic group (p<0.001), but there was no signifi cant diff erence in the 60-min serum PRL levels between the epileptic and nonepileptic groups (p>0.05). Considering diff erence within the groups according to timing, the 10-min serum PRL levels were higher than the 60-min serum PRL levels; the diff erence was statistically signifi cant (p<0.001). When syncope was compared between the nonepileptic group and other nonepileptic conditions (conversion, breath holding spell, night terror), it was found that the 10-min serum PRL levels were higher in syncope cases (p<0.01).
These results showed that serum PRL levels did not help differentiate cases of syncope and epilepsies; however, simple laboratory tests can diff erentiate syncope from other nonepileptic cases (conversion, breath holding spell, night terror). These results are consistent with those described in the literature. Again consistent with other studies, our results showed that serum PRL levels did not help diff erentiate epilepsies and syncopes. In these studies, Oribe et al. (16) showed that serum PRL levels were as high as those seen in epilepsies in 21 patients in whom they induced syncopes with tilt test. Leuf (15) showed that PRL was not helpful in diff erentiation of epileptic seizure and syncope; and fi nally Chen et al. (14) showed that serum PRL levels were not helpful in diff erentiating epileptic seizure and syncope. Based on the data recorded in our study, we determined that the time of measurement was the only factor aff ecting PRL level, and not any other factor (gender, EEG pathology, antiepileptic drug use, duration of seizures, etc.). Therefore, we believe that blood sample should be obtained from patients who are admitted to emergency policlinics with seizures (epileptic or nonepileptic) in the postictal period as soon as possible in order to evaluate PRL levels. Although we did not use PRL levels simultaneously with video-EEGs, we believe that PRL measurement is just as or even more important than video-EEGs in diff erentiation of ES from NES thanks to its accessibility where a laboratory is available. A limitation of this study was the fact that complex partial seizures were not taken as a separate group.
To conclude, serum PRL levels were found to be higher in the epileptic group and in syncope, which is a nonepileptic case, which is consistent with literature reports. We suggest that PRL levels be used to diff erentiate ES and NES in young children. We also determined that blood samples to be used for diff erential diagnosis should be obtained as soon as possible due to the fact that PRL reaches its peak at 10 min and regresses back to its baseline between 60 and 90 min. Extensive series of studies should be done to research the marker properties of serum PRL levels for the diff erential diagnosis of ES and NES in pediatric patients; timing of serum PRL measurement should be standardized; and simultaneous evaluation of serum PRL levels with video-EEGs will contribute to research in the fi eld. 
